NCT07495384

Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: The First Hospital of Jilin University · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This trial was designed as a single-arm, open-label, prospective clinical trial to evaluate the efficacy (ORR) and safety (AE incidence) of CapsuleX in combination with cisplatin for platinum-resistant recurrent ovarian cancer (PROC).

Conditions

• Recurrent Ovarian Cancer
• Platinum Resistance

Interventions

Type	Name	Description
DRUG	CapsuleX	CapsuleX Combined with Cisplatin

Timeline

• Start date: 2025-01-17
• Primary completion: 2029-11-01
• Completion: 2029-11-01
• First posted: 2026-03-27
• Last updated: 2026-03-27

Locations

1 site across 1 country: China